Is Aveanna Healthcare (AVAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
More News
LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare
Outpatient and home healthcare stocks gain from aging, digital care and AI, with LifeStance, Option Care, Aveanna and DaVita in focus.
Zacks
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
Zacks
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
Aveanna Healthcare (AVAH) Is Up 6.82% in One Week: What You Should Know
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
Zacks
Earnings Estimates Rising for Aveanna (AVAH): Will It Gain?
Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Aveanna raises its 2026 outlook and long-term growth targets as reimbursement gains and preferred payers support expansion.
Zacks
AVAH Crosses Above Average Analyst Target
In recent trading, shares of Aveanna Healthcare Holdings Inc (Symbol: AVAH) have crossed above the average analyst 12-month target price of $10.45, changing hands for $11.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: d...